K-Bank and Two Other Firms Launch IPO Subscriptions This Week—IPO Market Shows Signs of Revival

South Korea’s IPO market is regaining momentum as K-Bank, Esteem, and Xvis open public subscriptions this week, while biotech firms Cana Therapeutics and IMBiologics launch institutional demand forecasts, signaling renewed investor interest and robust competition ratios.